6/18/2019 6:29:23 AM
Wedbush Is Cutting Voyager Therapeutics (VYGR) FY19 Estimate To -3.59 From -3.19
6/18/2019 6:29:11 AM
Wedbush Is Cutting Voyager Therapeutics (VYGR) Q4 19 Estimate To -1.07 From -0.80
6/18/2019 6:28:51 AM
Wedbush Is Lowering Voyager Therapeutics (VYGR) Q2 19 Estimate To -0.91 From -0.78
6/18/2019 6:28:19 AM
Wedbush Reiterates Voyager Therapeutics (VYGR) At Outperform With $36 Up From $27 Price Target
6/17/2019 7:40:59 AM
Voyager Gains Worldwide Rights To VY-HTT01 Huntington’s Disease Program
2/28/2019 8:42:30 AM
Wedbush Is Lowering Voyager Therapeutics (VYGR) FY19 Rev. Estimate To 20.0 M From 125.5 M
2/28/2019 8:42:19 AM
Wedbush Is Lowering Voyager Therapeutics (VYGR) Q4 19 Rev. Estimate To 5.0 M From 31.4 M
2/28/2019 8:42:13 AM
Wedbush Is Lowering Voyager Therapeutics (VYGR) Q3 19 Rev. Estimate To 5.0 M From 31.4 M
2/28/2019 8:42:08 AM
Wedbush Is Lowering Voyager Therapeutics (VYGR) Q2 19 Rev. Estimate To 5.0 M From 31.4 M
2/28/2019 8:41:59 AM
Wedbush Is Lowering Voyager Therapeutics (VYGR) Q1 19 Rev. Estimate To 5.0 M From 31.4 M
2/28/2019 8:41:41 AM
Wedbush Is Cutting Voyager Therapeutics (VYGR) FY19 Estimate To -2.18 From 1.39
2/28/2019 8:41:13 AM
Wedbush Is Cutting Voyager Therapeutics (VYGR) Q4 19 Estimate To -0.63 From 0.31
2/28/2019 8:41:02 AM
Wedbush Is Lowering Voyager Therapeutics (VYGR) Q3 19 Estimate To -0.56 From 0.34
2/28/2019 8:40:50 AM
Wedbush Is Cutting Voyager Therapeutics (VYGR) Q2 19 Estimate To -0.49 From 0.37
2/28/2019 8:40:39 AM
Wedbush Is Cutting Voyager Therapeutics (VYGR) Q1 19 Estimate To -0.50 From 0.37
2/22/2019 8:06:01 AM
AbbVie And Voyager Collaborate To Develop Vectorized Antibodies To Treat Parkinson's Disease And Other Synucleinopathies